Senthil Jayarajan, Joseph J. Meissler, Martin W. Adler, & Toby K. Eisenstein. (2022). A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo. Frontiers Media S.A..
Chicago Style (17th ed.) CitationSenthil Jayarajan, Joseph J. Meissler, Martin W. Adler, and Toby K. Eisenstein. A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationSenthil Jayarajan, et al. A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.